Monday, May 1, 2017

New Imaging Method May Predict Immunotherapy Response Early

A noninvasive PET imaging method that measures granzyme B, a protein released by immune cells to kill cancer cells, was able to distinguish mouse and human tumors that responded to immune checkpoint inhibitors from those that did not respond early in the course of treatment, according to data published in Cancer Research, a journal of the American Association for Cancer Research.Link to full AACR release on study led by MGH investigator Umar Mahmood.

Browse the Entire Newsroom Archive

Back to Top